Pipeline

Category
Program
MOA (Modality)
Indication
IND-Enabling
Phase 1
Phase 2
Phase 3
Approved
Status
Oncology
HS-110
gp96 + CTAs (Cell Therapy)
NSCLC
End-of-Ph 2 Planning
HS-130
OX40L (Cell Therapy)
Solid Tumors
Ph 1 Enrollment Complete
Full Nighthawk Pipeline